Solution state characterization of amyloid beta-derived diffusible ligands.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 17176037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• Small non-fibrillar assemblies of amyloid beta-protein bearing the Arctic mutation induce rapid neuritic degeneration.

  2005cited by this paper
• Neurotoxic protein oligomers — what you see is not always what you get

  2005cited by this paper
• Fine structure study of Aβ1–42 fibrillogenesis with atomic force microscopy

  2005cited by this paper
• Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

  2005cited by this paper
• Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.

  2005cited by this paper
• Nucleation-Dependent Polymerization Is an Essential Component of Amyloid-Mediated Neuronal Cell Death

  2005cited by this paper
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

  2005cited by this paper
• Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain.

  2005cited by this paper
• Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦

  2005cited by this paper
• Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons.

  2005cited by this paper
• Imaging proteins with atomic force microscopy: an overview.

  2005cited by this paper
• Rapid photochemical cross-linking--a new tool for studies of metastable, amyloidogenic protein assemblies.

  2004cited by this paper
• Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

  2004cited by this paper
• Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases*

  2004cited by this paper
• Self-assembly of Abeta(1-42) into globular neurotoxins.

  2003cited by this paper
• Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss

  2003cited by this paper
• In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis*

  2003cited by this paper
• AFM and STM study of beta-amyloid aggregation on graphite.

  2003cited by this paper
• Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-beta in vitro.

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• ADDLs & protofibrils--the missing links?

  2002cited by this paper
• Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability*

  2002cited by this paper
• Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid.

  2002cited by this paper
• Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies

  2001cited by this paper
• Salvianolic acid B inhibits fibril formation and neurotoxicity of amyloid beta-protein in vitro.

  2001cited by this paper
• Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation.

  2000cited by this paper
• Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.

  2000cited by this paper
• A method for directly fitting the time derivative of sedimentation velocity data and an alternative algorithm for calculating sedimentation coefficient distribution functions.

  2000cited by this paper
• Interaction of Amyloid Beta-Protein with Anionic Phospholipids: Possible Involvement of Lys28 and C-Terminus Aliphatic Amino Acids

  2000cited by this paper
• GM1 inhibits amyloid beta-protein-induced cytokine release.

  1999cited by this paper
• In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation.

  1999cited by this paper
• Analysis of amyloid-beta assemblies using tapping mode atomic force microscopy under ambient conditions.

  1999cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Structural Transitions Associated with the Interaction of Alzheimer β-Amyloid Peptides with Gangliosides*

  1998cited by this paper
• Acceleration of Amyloid Fibril Formation by Specific Binding of Aβ-(1–40) Peptide to Ganglioside-containing Membrane Vesicles*

  1997cited by this paper
• Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

  1997cited by this paper
• On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants.

  1996cited by this paper
• The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy.

  1996cited by this paper
• Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.

  1995cited by this paper
• Chromatographic separation of low-molecular-mass recombinant proteins and peptides on Superdex 30 prep grade.

  1994cited by this paper
• Boundary analysis in sedimentation transport experiments: a procedure for obtaining sedimentation coefficient distributions using the time derivative of the concentration profile.

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper

• Aducanumab binds high molecular weight soluble Aβ oligomers and restores intracellular calcium levels

  2025cites this paper
• Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

  2024cites this paper
• Biological Effects and Mechanisms of Taurine in Various Therapeutics.

  2023cites this paper
• IM-MS and ECD-MS/MS Provide Insight into Modulation of Amyloid Proteins Self-Assembly by Peptides and Small Molecules.

  2023cites this paper
• EPR Studies of Aβ42 Oligomers Indicate a Parallel In-Register β-Sheet Structure

  2023cites this paper
• Amyloid-β: A potential mediator of aging-related vascular pathologies.

  2023cites this paper
• Amyloid- β Oligomers: Multiple Moving Targets

  2022cites this paper
• Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers

  2022cites this paper
• Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives

  2022cites this paper
• ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease

  2022cites this paper
• Novel Stilbene-Nitroxyl Hybrid Compounds Display Discrete Modulation of Amyloid Beta Toxicity and Structure

  2022cites this paper
• Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids.

  2021cites this paper
• Defining the Neuropathological Aggresome across in Silico, in Vitro, and ex Vivo Experiments.

  2021cites this paper
• Amyloids: The History of Toxicity and Functionality

  2021cites this paper
• The interplay between lipid and Aβ amyloid homeostasis in Alzheimer's Disease: risk factors and therapeutic opportunities.

  2021cites this paper
• Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer’s disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma

  2021cites this paper
• Out-of-register parallel β-sheets and antiparallel β-sheets coexist in 150 kDa oligomers formed by Amyloid-β(1-42).

  2020cites this paper
• Out-of-register parallel β-sheets and antiparallel β-sheets coexist in 150 kDa oligomers formed by Aβ(1-42)

  2020cites this paper
• Potential of Microfluidics and Lab-on-Chip Platforms to Improve Understanding of “prion-like” Protein Assembly and Behavior

  2020cites this paper
• Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers

  2020cites this paper
• Content of anti-β-amyloid42 oligomers antibodies in multiple batches from different immunoglobulin preparations.

  2020cites this paper
• Inflammatory mechanisms in neurodegeneration

  2019cites this paper
• Three Structural Features of Functional Food Components and Herbal Medicine with Amyloid β42 Anti-Aggregation Properties

  2019cites this paper
• PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins

  2019cites this paper
• NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril

  2019cites this paper
• Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain.

  2019cites this paper
• Investigation of Amyloid β Oligomer Dissociation Mechanisms by Single Molecule Fluorescence Techniques

  2019influential citation
• Shedding light on aberrant interactions – a review of modern tools for studying protein aggregates

  2018cites this paper
• Aptamers Selected for Recognizing Amyloid β-Protein—A Case for Cautious Optimism

  2018cites this paper
• 1 Aptamers Selected for Recognizing Amyloid 2 β-protein — A Case for Cautious Optimism 3

  2018cites this paper
• Prion Protein as a Toxic Acceptor of Amyloid-β Oligomers.

  2018cites this paper
• Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent

  2018cites this paper
• Spectroscopic Signature for Stable β-Amyloid Fibrils versus β-Sheet-Rich Oligomers.

  2018cites this paper
• An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging

  2018cites this paper
• CD34 and CD117 Stemness of Lineage-Negative Cells Reverses Memory Loss Induced by Amyloid Beta in Mouse Model

  2018cites this paper
• Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.

  2017cites this paper
• Why Are Functional Amyloids Non-Toxic in Humans?

  2017cites this paper
• Soluble Aβ aggregates can inhibit prion propagation

  2017cites this paper
• Neuroprotective astrocyte-derived insulin/insulin-like growth factor 1 stimulates endocytic processing and extracellular release of neuron-bound Aβ oligomers

  2017influential citation
• Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls

  2017cites this paper
• Structure‐dependent effects of amyloid‐β on long‐term memory in Lymnaea stagnalis

  2017cites this paper
• Stabilization of native amyloid β-protein oligomers by Copper and Hydrogen peroxide Induced Cross-linking of Unmodified Proteins (CHICUP).

  2016cites this paper
• Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease.

  2016cites this paper
• Title Amyloid-Protein Dimers Rapidly Form Stable SynaptotoxicProtofibrils

  2016cites this paper
• Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer’s Disease Immunotherapy

  2016cites this paper
• Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

  2016cites this paper
• Fine mapping of the Aβ oligomer binding site on PrP

  2016influential citation
• Amyloid-β and amyloid associated proteins in the pathology and diagnosis of Alzheimer's disease

  2016influential citation
• A Modified Stokes-Einstein Equation for A Beta Aggregation

  2016cites this paper
• The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy

  2016cites this paper
• Amyloid Beta (Aβ) Peptide and Factors that Play Important Roles in Alzheimer's Disease.

  2016cites this paper
• The amyloid cascade hypothesis: are we poised for success or failure?

  2016cites this paper
• The Aggregation Paths and Products of Aβ42 Dimers Are Distinct from Those of the Aβ42 Monomer.

  2016cites this paper
• Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer’s disease and track disease progression and cognitive decline

  2016cites this paper
• A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid

  2015cites this paper
• [Physico-chemical methods for studing β-amyloid aggregation].

  2015cites this paper
• Biophysical comparison of soluble amyloid-β(1-42) protofibrils, oligomers, and protofilaments.

  2015cites this paper
• C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death

  2015cites this paper
• Amyloid β Oligomeric Species Present in the Lag Phase of Amyloid Formation

  2015cites this paper
• Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives

  2015cites this paper
• Analyzing dendritic spine pathology in Alzheimer’s disease: problems and opportunities

  2015cites this paper
• Aβ’s effect on long term memory: a top-down approach in Lymnaea stagnalis

  2015cites this paper
• Solvent exposure of Tyr10 as a probe of structural differences between monomeric and aggregated forms of the amyloid-β peptide

  2015cites this paper
• The aqueous phase of Alzheimer's disease brain contains assemblies built from ∼4 and ∼7 kDa Aβ species

  2015cites this paper
• RNA Aptamer Probes as Optical Imaging Agents for the Detection of Amyloid Plaques

  2014cites this paper
• Transient dynamics of Aβ contribute to toxicity in Alzheimer’s disease

  2014cites this paper
• In Search of Aggregation Pathways of IAPP and Other Amyloidogenic Proteins: Finding Answers through NMR Spectroscopy.

  2014cites this paper
• Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics

  2014cites this paper
• The effects of soluble Aβ oligomers on neurodegeneration in Alzheimer's disease.

  2014cites this paper
• A Sensitive Aβ Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid

  2014influential citation
• Aβ40 modulates GABAA receptor α6 subunit expression and rat cerebellar granule neuron maturation through the ERK/mTOR pathway

  2014cites this paper
• Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer‐induced AMPA glutamate receptor signaling deficits

  2014cites this paper
• Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model.

  2014cites this paper
• Antiparallel Triple-strand Architecture for Prefibrillar Aβ42 Oligomers*

  2014cites this paper
• Amyloid-forming proteins alter the local mechanical properties of lipid membranes.

  2013cites this paper
• Accumulation of Intraneuronal β-Amyloid 42 Peptides Is Associated with Early Changes in Microtubule-Associated Protein 2 in Neurites and Synapses

  2013cites this paper
• Nucleation process of a fibril precursor in the C-terminal segment of amyloid-β.

  2013cites this paper
• Investigating Interventions in Alzheimer's Disease with Computer Simulation Models

  2013cites this paper
• Extracellular Calcium Modulates Actions of Orthosteric and Allosteric Ligands on Metabotropic Glutamate Receptor 1α*

  2013cites this paper
• Amyloid-β Protofibrils: Size, Morphology and Synaptotoxicity of an Engineered Mimic

  2013cites this paper
• Amyloid β-protein oligomers and Alzheimer’s disease

  2013cites this paper
• N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody

  2013cites this paper
• Globular and protofibrillar aβ aggregates impair neurotransmission by different mechanisms.

  2013cites this paper
• The Off-rate of Monomers Dissociating from Amyloid-β Protofibrils*

  2013cites this paper
• Analytical model and multiscale simulations of Aβ peptide aggregation in lipid membranes: towards a unifying description of conformational transitions, oligomerization and membrane damage.

  2013cites this paper
• AMPA Glutamate Receptor Trafficking in Models of Disease

  2013cites this paper
• Caractérisation des oligomères β-amyloïdes cérébraux et vasculaires impliqués dans la maladie d’Alzheimer

  2013cites this paper
• Characterisation of different amyloid-ß aggregates in Alzheimer's disease

  2012influential citation
• Taurine and central nervous system disorders

  2012cites this paper
• Manuscript in preparation : I . Aging in Rats Promotes Alzheimer ’ s Disease β-amyloid Aggregation and Toxicity by Metallostasis of Extraneuronal Zinc

  2012cites this paper
• Application of photochemical cross-linking to the study of oligomerization of amyloidogenic proteins.

  2012cites this paper
• Neutralization of Soluble, Synaptotoxic Amyloid β Species by Antibodies Is Epitope Specific

  2012cites this paper
• Multivariate Analyses of Amyloid-Beta Oligomer Populations Indicate a Connection between Pore Formation and Cytotoxicity

  2012cites this paper
• A peptide probe for detection of various beta-amyloid oligomers.

  2012cites this paper
• Methods for Analysis of Amyloid-β Aggregates

  2012cites this paper
• Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits.

  2012cites this paper
• Modulation of beta-amyloid aggregation by engineering the sequence connecting beta-strand forming domains.

  2012cites this paper
• Specific Recognition of Biologically Active Amyloid-β Oligomers by a New Surface Plasmon Resonance-based Immunoassay and an in Vivo Assay in Caenorhabditis elegans*

  2012influential citation
• Alzheimer's disease and the amyloid β-protein.

  2012cites this paper
• The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

  2012cites this paper